Pulmonary Vasodilator Response of Combined Inhaled Epoprostenol and Inhaled Milrinone in Cardiac Surgical Patients

Abstract

BACKGROUND: Pulmonary hypertension (PH) and right ventricular (RV) dysfunction are major complications in cardiac surgery. Intraoperative management of patients at high risk of RV failure should aim to reduce RV afterload and optimize RV filling pressures, while avoiding systemic hypotension, to facilitate weaning from cardiopulmonary bypass (CPB). Inhaled epoprostenol and inhaled milrinone (iE&iM) administered in combination before CPB may represent an effective strategy to facilitate separation from CPB and reduce requirements for intravenous inotropes during cardiac surgery. Our primary objective was to report the rate of positive pulmonary vasodilator response to iE&iM and, second, how it relates to perioperative outcomes in cardiac surgery. METHODS: This is a retrospective cohort study of consecutive patients with PH or RV dysfunction undergoing on-pump cardiac surgery at the Montreal Heart Institute from July 2013 to December 2018 (n = 128). iE&iM treatment was administered using an ultrasonic mesh nebulizer before the initiation of CPB. Demographic and baseline clinical data, as well as hemodynamic, intraoperative, and echocardiographic data, were collected using electronic records. An increase of 20% in the mean arterial pressure (MAP) to mean pulmonary artery pressure (MPAP) ratio was used to indicate a positive response to iE&iM. RESULTS: In this cohort, 77.3% of patients were responders to iE&iM treatment. Baseline systolic pulmonary artery pressure (SPAP) (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.24-2.16 per 5 mm Hg; P = .0006) was found to be a predictor of pulmonary vasodilator response, while a European System for Cardiac Operative Risk Evaluation (EuroSCORE II) score >6.5% was a predictor of nonresponse to treatment (≤6.5% vs >6.5% [reference]: OR, 5.19; 95% CI, 1.84-14.66; P = .002). Severity of PH was associated with a positive response to treatment, where a higher proportion of responders had MPAP values >30 mm Hg (42.4% responders vs 24.1% nonresponders; P = .0237) and SPAP values >55 mm Hg (17.2% vs 3.4%; P = .0037). Easier separation from CPB was also associated with response to iE&iM treatment (69.7% vs 58.6%; P = .0181). A higher proportion of nonresponders had a very difficult separation from CPB and required intravenous inotropic drug support compared to responders, for whom easy separation from CPB was more frequent. Use of intravenous inotropes after CPB was lower in responders to treatment (8.1% vs 27.6%; P = .0052). CONCLUSIONS: A positive pulmonary vasodilator response to treatment with a combination of iE&iM before initiation of CPB was observed in 77% of patients. Higher baseline SPAP was an independent predictor of pulmonary vasodilator response, while EuroSCORE II >6.5% was a predictor of nonresponse to treatment. (Anesth Analg 2023;136:282-94) KEY POINTS• Question: Can a combination of inhaled epoprostenol and inhaled milrinone (iE&iM) administered before cardiopulmonary bypass (CPB) provide a positive pulmonary vasodilator response? • Findings: A positive pul...

Longitudinal Validation of Right Ventricular Pressure Monitoring for the Assessment of Right Ventricular Systolic Dysfunction in a Large Animal Ischemic Model

“…Those will help in determining how sensitive changes in dP/dt are in detecting abnormal RV dysfunction. We have, however, reported that increases in dP/dt were clearly associated with improvement in RV function ( 32 , 47 , 48 )…”

“…Those will help in determining how sensitive changes in dP/dt are in detecting abnormal RV dysfunction. We have, however, reported that increases in dP/dt were clearly associated with improvement in RV function (32,47,48) Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (http://journals.lww.com/ccejournal).…”

Prolonged cardiovascular pharmacological support and fluid management after cardiac surgery

“…Inhaled vasodilators used before and after CPB could represent a potential strategy in reducing vasoactive support. The hemodynamic efficacy combining inhaled prostacyclin and milrinone is close to 80% cardiac surgery [ 35 , 36 ]. Reduction of vasoactive support has been by a retrospective analysis using this approach [ 37 ].…”

Hemodynamic management during off-pump coronary artery bypass surgery: a narrative review of proper targets for safe execution and troubleshooting

“…Other things to consider are that the pulmonary artery pressure usually increases during mechanical heart displacement, especially during lateral wall grafting, due to the increased left atrial pressure and impaired diastolic filling [9,14]. Accordingly, possible rescue for RV dysfunction in conjunction with increased pulmonary artery pressure would include application of inhaled milrinone (possibly in combination with epoprostenol) [53], which would act more on the pulmonary vasculature to relieve the afterload of the RV in addition to the inherent inotropic action. Yet, their efficacy in OPCAB remains to be proven, while a case report has been made regarding the beneficial effect of inhaled epoprostenol on relieving RV afterload and venous congestion [54].…”